Neurology Diagnostics Inc.

07/02/2025

This past week our highly skilled physicians attended an investigator meeting for a new migraine study. This study will offer a Botox bio similar aimed at reducing frequency and severity of migraines.

We will begin screening for this new trial in the next couple of weeks! If you or someone you know suffers from chronic migraines, and has never received Botox injections in the past, please contact our staff to learn more.

937-225-8200 opt 5
Research@neurologydiagnostics.com

Our dedicated team at NDx Clinical Research recently traveled to attend an exclusive investigator meeting for an exciting new clinical trial evaluating a new bi

05/07/2025

Worried about a loved one's fading memories?
Memory loss can be frightening — but there’s help and hope. Neurology Diagnostics is currently enrolling for an Alzheimer’s clinical trial aimed at advancing treatment options.

👨‍⚕️ No-cost participation
🚶‍♂️ Help improve future care
🧠 Contribute to vital Alzheimer’s research

🔗 Visit www.neurologydiagnostics.com/contents/alzheimers-clinical-trials to learn more or see if they qualify.

05/03/2025

Neurology Diagnostics is now enrolling participants for an Alzheimer’s clinical study. If you or a loved one are experiencing memory issues, you may qualify for research that could make a difference.

📍 No cost to participate
💊 Access to potential new treatment options
🧪 Help advance Alzheimer’s research

👉 Learn more and see if you qualify: www.neurologydiagnostics.com

04/09/2025

With Relapsing Multiple Sclerosis, symptoms ease—only to return again. But research is working to create longer relief and fewer setbacks. By joining a clinical trial, you can help shape the future of RMS treatment and move science forward.

📍 Learn more & enroll today:www.neurologydiagnostics.com | 📞 937-224-8200, ext. 5

04/06/2025

Relapsing Multiple Sclerosis can make progress feel temporary, with symptoms returning when least expected. But science is working to create longer-lasting relief.

Join our clinical trial and help researchers develop better treatments for Multiple Sclerosis.

📍 Learn more & enroll today: www.neurologydiagnostics.com | 📞 937-224-8200, ext. 5

04/03/2025

Relapsing Multiple Sclerosis feels like waves—calm moments of relief followed by unpredictable relapses. The cycle repeats, making stability uncertain. But science is working to change that.

Help calm the tide. Join our RRMS clinical trial and be part of the breakthrough.

📍 Learn more & enroll today:www.neurologydiagnostics.com | 📞 937-224-8200, ext. 5

04/01/2025

RMS is unpredictable, but research is working toward better solutions. If you’re living with the daily challenges of relapses and uncertainty, you may qualify for our clinical trial.

Swipe through to learn more and see if you’re eligible. Your participation could help shape the future of RMS treatment.

📍 Learn more & enroll today:www.neurologydiagnostics.com | 📞 937-224-8200, ext. 5

03/29/2025

Multiple Sclerosis (MS) disrupts the communication between the brain and muscles, making everyday movements a challenge. But there’s hope! 🌟

Join our MS Clinical Trials and be a part of groundbreaking research aimed at restoring this lost dialogue. Together, we can make a difference!

📍 Learn more & enroll today:www.neurologydiagnostics.com | 📞 937-224-8200, ext. 5

03/27/2025

Breakthroughs in Relapsing MS treatment are here—and you can be part of the change. Join our clinical trials to access cutting-edge therapies while helping shape the future of MS care. 💙

Learn more: www.neurologydiagnostics.com | 📞 937-224-8200, ext. 5

02/13/2025

Are you or your loved one living with Multiple sclerosis, you may be eligible for the Oak Study. Click here to see if you're eligible: https://form.typeform.com/to/BTqPmEnH

National Multiple Sclerosis Society

10/02/2024

It's OCTOBER!

09/27/2024

Hi Everyone! The clinical research department at Neurology Diagnostics is happy to share we will start offering free cognitive testing. If you are 50 years and older, having concerns regarding your memory or have a strong family history of dementia, we encourage you to call us or use the link below to request an appointment. These appointments take approximately 15 minutes, in which you will be given a Montreal Cognitive assesment designed to test executive functioning, naming, memory, attention, language, abstract thinking, delayed recall and orientation.

MoCA (Montreal Cognitive Assessment or The MoCA Test) was validated as a highly sensitive tool for early detection of mild cognitive impairment (MCI) in hundreds of peer-reviewed studies since 2000. MoCA has been widely adopted in clinical settings and used in academic and non-academic research around the world. The assessment is the earliest and most accurate detection of mild cognitive impairment with a sensitivity of detecting MCI with 90% accuracy. (https://mocacognition.com)

Use this link below or call 937-224-8200 ext 5 to request to speak with a research staff member and scheudle this free assesment.

https://forms.office.com/r/xsf0nX4BuL

Thank you all!